(firstQuint)Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care.

 This is a multi-centre study conducted in four countries.

 A total of 60 subjects with Alzheimer's disease who are on standard-of-care will be enrolled to receive one of 3 active HTL0018318 or placebo for a period of four weeks.

 Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care@highlight

Multi-centre study of HTL0018318 in patients with Alzheimer's disease as an add-on to standard-of-care